Cocrystal Pharma, Inc.
COCP
$1.24
$0.065.09%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.16M | -2.30M | -2.43M | -2.05M | -2.06M |
| Total Depreciation and Amortization | 12.00K | 12.00K | 13.00K | 13.00K | 21.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.00K | 163.00K | 56.00K | 199.00K | 10.00K |
| Change in Net Operating Assets | 623.00K | -216.00K | 621.00K | 475.00K | -131.00K |
| Cash from Operations | -2.52M | -2.34M | -1.74M | -1.36M | -2.16M |
| Capital Expenditure | -- | -- | 0.00 | -12.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 0.00 | -12.00K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 1.03M | 4.34M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 1.03M | 4.34M | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.52M | -2.34M | -704.00K | 2.96M | -2.16M |